KidneyCAN joins nearly 200 other patient advocacy, public health, and health care professional organizations signing on to a letter from the American Cancer Society endorsing strong support for the Clinical Trial Modernization Act (S. 4440/H.R. 3521). This was introduced by Senators Tim Scott (R-SC) and Mark Warner (D-VA) in the Senate in April 2026 and House Representatives Raul Ruiz (D-CA) and August Pfluger (R-TX) in the House in May 2025.

You can read more about the Clinical Trial Modernization Act and the letter sent by the ACS here.